Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Endeavor Biomedicines, Inc., explained in plain language.
This study tests an experimental drug called ENV-101 in 213 adults with idiopathic pulmonary fibrosis (IPF), a disease that scars the lungs and makes breathing hard. The goal is to see if ENV-101 can improve lung function and slow disease progression compared to a placebo. Partic…
Phase: PHASE2 • Sponsor: Endeavor Biomedicines, Inc. • Aim: Disease control
Last updated May 26, 2026 11:36 UTC